Sinovac Biotech, one of the major inactivated vaccine manufactures in China, has reportedly halted COVID-19 vaccine production. The company did not confirm the news but industry observers believe it is a response to falling market demand.
A circulated document from Sinovac Life Sciences Co., Ltd titled "Scheme for Suspending Performance Bonuses for COVID-19 Projects" indicated that the company completely halted their production of COVID-19 vaccines, with vaccine products no longer on sale, according to Jimu News, a media outlet affiliated with Hubei Daily.
Sinovac Life Sciences is a subsidiary of Sinovac Biotech Ltd, one of the main inactivated vaccine manufactures in China. The document said that the company has decided to stop issuing performance bonuses for employees involved in the COVID-19 project starting from January 2024.
Citing one staff member from the product consultation hotline of Sinovac Biotech, Jimu News confirmed that the company's COVID-19 vaccine has indeed been discontinued. The report quoted the staff member as saying that if there is a need for the product, individuals would have to inquire with the local disease control center about its availability.
